Persistent Müllerian duct syndrome

From Food & Medicine Encyclopedia

Revision as of 23:49, 27 May 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

autorecessive

Persistent Müllerian duct syndrome (PMDS) is a rare form of intersex condition in which individuals with a typically male karyotype (46,XY) and normal male external genitalia also have internal female reproductive structures, such as a uterus and fallopian tubes. This condition is caused by a failure in the regression of the Müllerian ducts during fetal development.

Pathophysiology

In typical male fetal development, the Müllerian ducts regress due to the secretion of Anti-Müllerian hormone (AMH) by the Sertoli cells of the testes. In PMDS, this process is disrupted, leading to the persistence of these ducts. The disruption can be due to mutations in the AMH gene or the AMH receptor gene, resulting in either a lack of AMH production or a failure of the body to respond to AMH.

Clinical Presentation

Individuals with PMDS usually present with normal male external genitalia and undescended testes (cryptorchidism). The presence of a uterus and fallopian tubes is often discovered incidentally during surgery for cryptorchidism or inguinal hernia repair. In some cases, the condition may be associated with infertility.

Diagnosis

Diagnosis of PMDS is typically made through a combination of clinical examination, imaging studies such as ultrasound or MRI, and genetic testing to identify mutations in the AMH or AMH receptor genes. Hormonal assays may also be conducted to assess levels of AMH and other relevant hormones.

Treatment

The primary treatment for PMDS involves surgical management of cryptorchidism to reduce the risk of testicular cancer and to potentially improve fertility. The removal of the persistent Müllerian structures is generally not necessary unless they cause symptoms or complications.

Prognosis

The prognosis for individuals with PMDS is generally good, especially if cryptorchidism is managed appropriately. However, there may be an increased risk of infertility and testicular cancer, necessitating regular follow-up and monitoring.

Related Pages

See Also

References

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.